Ypsomed Holding AG
YPSN
Rang in aandelen
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Aandeelprijs
$469.39
Marktkapitalisatie
$6.17B
Verandering (1 dag)
1.63%
Verandering (1 jaar)
18.98%
Land
CH
Handel Ypsomed Holding AG (YPSN)
Categorie
Healthcare
Aantal uitstaande aandelen voor Ypsomed Holding AG (YPSN)
Aantal uitstaande aandelen per October 2026: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Ypsomed Holding AG bedraagt het huidige aantal uitstaande aandelen 0. Aan het einde van October 2026 had het bedrijf 0 uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Ypsomed Holding AG (YPSN) van 2002 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2025 | 13.65M | 0.00% |
| 2024 | 13.65M | 1.74% |
| 2023 | 13.42M | 5.79% |
| 2022 | 12.68M | 0.26% |
| 2021 | 12.65M | 0.07% |
| 2020 | 12.64M | 0.31% |
| 2019 | 12.60M | 0.13% |
| 2018 | 12.59M | -0.22% |
| 2017 | 12.61M | -0.09% |
| 2016 | 12.62M | 0.00% |
| 2015 | 12.62M | 0.08% |
| 2014 | 12.61M | 0.00% |
| 2013 | 12.61M | -0.31% |
| 2012 | 12.65M | -0.05% |
| 2011 | 12.66M | 5.40% |
| 2010 | 12.01M | 6.69% |
| 2009 | 11.26M | -0.08% |
| 2008 | 11.27M | 0.03% |
| 2007 | 11.26M | -0.08% |
| 2006 | 11.27M | -0.05% |
| 2005 | 11.28M | 351.15% |
| 2004 | 2.50M | -0.28% |
| 2003 | 2.51M | -77.77% |
| 2002 | 11.28M | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| 97.60M | - |
IE
|
|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| 52.26M | - |
KR
|
